SALT LAKE CITY, May 26, 2022 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who have ...
LOS ANGELES, CA--(Marketwired - Jul 24, 2014) - Today, Elevar Global announced its selection of award-winning agency, Marketing Maven, as the exclusive provider of key service offerings. Effective ...
Editor's Note: Since this story's original publication on July 10, Elevar has adjusted its expected refile timeline and the story has been updated to reflect that. After a meeting with the FDA last ...
The MarketWatch News Department was not involved in the creation of this content. FORT LEE, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., ...
The combo therapy aside, Hengrui in 2020 scored a China approval for rivoceranib monotherapy under the brand name Aitan in second-line treatment for advanced HCC ...
FORT LEE, N.J., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Group and a fully integrated biopharmaceutical company dedicated to elevating treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results